Sprinkles late. Morning clouds. Mild.
Aspen Pharmacare says its sale of New Zealand infant-formula business to French company Lactalis International has been approved by authorities
Aspen Pharmacare has received approval from the China Food and Drug Administration to register its Aspen infant milk formula Alula in China.
Just because medicine prices are regulated, does not mean they are fair or competitive.
Aspen Pharmacare says it has signed off on an agreement with GlaxoSmithKline to acquire a portfolio of anaesthetics.
Aspen Pharmacare has posted a gain in profit, beating expectations as the expansion of its international business outweighed the cost of imported materials.
Aspen Pharmacare, Africa's biggest drugmaker by value, has missed forecasts with an almost one-third rise in full-year profit.
Shares in Adcock Ingram took a beating after the Public Investment Corporation said its deal with Chile's CFR Pharmaceuticals is not in the best interest of its shareholders.
Aspen Pharmacare says talks with Britain's GlaxoSmithKline about its $700 bid for drugs and a factory continues.
GlaxoSmithKline has advanced its clear-out of non-core drugs with a deal to sell 25 older brands marketed in Australia to South Africa's Aspen Pharmacare.
Aspen Pharmacare sees China eventually overtaking South Africa as its biggest market as the firm completes its transition to a global therapeutics business from an Africa-focused generic-drugs maker.
The Competition Commission has announced it would be dropping its investigation against Aspen over excessive pricing for cancer medicines as it could not be substantiated.
Regulators in the European Union say they’ll check that Aspen Pharmacare conducted "so-called price-gouging" by imposing price increases of up to several hundred percent.
GlaxoSmithKline will dispose of its remaining stake in Aspen Pharmacare less than a month after selling the SA company a portfolio of anaesthetic medicines.
The National Health Department has awarded a R10bn tender to four pharmaceutical firms to supply Aids treatment drugs.
Shares on the JSE rose even though resources came under pressure as Anglo American Platinum said it was reviewing options for its Rustenburg operations.
UK drug maker GlaxoSmithKline has agreed to sell its thrombosis drug brands and a related factory to Aspen Pharmacare for £700m.
Aspen Pharmacare is to acquire drugs and a manufacturing business from Merck in a $1bn deal to bolster its presence in Europe, Latin America and Asia.
Aspen Pharmacare says its headline earnings from continuing operations rose by 35% to R1.147bn for the half-year ended December 2010.
Somerset WestAfrica Experience Collection (PTY) LTDR40 000.00 - R70 000.00 Per Month
MosselbaaiCalandria Labour Consultants
R 2 960 000
R 2 350 000
R 11 800 000
We subscribe to the Press Code.
You choose what you want
News24 on Android
Get the latest from News24 on your Android device.
Terms and Conditions
24.com Terms and Conditions - Updated April 2012
Creating your profile will enable you to submit photos and stories to get published on News24.
This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.